Enzamide 40 mg

Enzalutamide 40 mg Capsules

Brands: Bdenza / Glenza / Enzamide
Generic Name: Enzalutamide
Manufactured by: BDR Pharmaceuticals
Country of Origin: India

Product Overview:

Enzalutamide 40 mg is an allopathic medicine used in the treatment of advanced prostate cancer. It belongs to a class of drugs known as androgen receptor inhibitors, which work by blocking the effects of male hormones (androgens) that can promote the growth of prostate cancer cells.

International Brand Equivalent:

Internationally marketed as Xtandi® (Enzalutamide 40 mg) by Astellas Pharma.

Available Brands in India:

• Bdenza

• Glenza

• Enzamide

Composition:

Each capsule contains:
Enzalutamide 40 mg

Dosage Form:

• Form: Capsule

• Dose Strength: 40 mg

Packaging Details:

• Packaging Type: Strip

• Capsules per Strip: 28

• Strips per Box: 4

• Total Capsules per Box: 112

Key Features:

• Used in the management of metastatic castration-resistant prostate cancer (mCRPC).

• Oral administration for patient convenience.

• Quality-assured by BDR Pharmaceuticals, a reputable Indian manufacturer.

• Export quality product compliant with international standards.